Education
About Us
Working with TipRanks
Follow Us
Fuji Pharma Co., Ltd. (DE:FUP)
FRANKFURT:FUP
Total Valuation
Fuji Pharma Co., Ltd. has a market cap or net worth of €195.54M. The enterprise value is €57.38B.
Market Cap€195.54M
Enterprise Value€57.38B
Share Statistics
Fuji Pharma Co., Ltd. has 24,863,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding24,863,600
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Fuji Pharma Co., Ltd.’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 3.74%.
Return on Equity (ROE)0.13
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)3.74%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee27.83M
Profits Per Employee4.99M
Employee Count1,658
Asset Turnover0.51
Inventory Turnover1.57
Valuation Ratios
The current PE Ratio of Fuji Pharma Co., Ltd. is 5.03. Fuji Pharma Co., Ltd.’s PEG ratio is -0.36.
PE Ratio5.03
PS Ratio0.00
PB Ratio0.70
Price to Fair Value0.68
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio-0.36
Income Statement
In the last 12 months, Fuji Pharma Co., Ltd. had revenue of 46.14B and earned 6.15B in profits. Earnings per share was 252.85.
Revenue46.14B
Gross Profit17.84B
Operating Income3.88B
Pretax Income8.28B
Net Income6.15B
EBITDA12.15B
Earnings Per Share (EPS)252.85
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Fuji Pharma Co., Ltd. pays an annual dividend of €0.137, resulting in a dividend yield of 3.59%
Dividend Per Share€0.137
Dividend Yield3.59%
Payout Ratio17.24%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.53
52-Week Price Change-5.13%
50-Day Moving Average8.00
200-Day Moving Average8.33
Relative Strength Index (RSI)52.30
Average Volume (3m)0.00
Important Dates
Fuji Pharma Co., Ltd. upcoming earnings date is Aug 7, 2025, TBA Not Confirmed.
Last Earnings DateMay 8, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend DateSep 29, 2025
Financial Position
Fuji Pharma Co., Ltd. as a current ratio of 1.19, with Debt / Equity ratio of 70.78%
Current Ratio1.19
Quick Ratio0.68
Debt to Market Cap0.78
Net Debt to EBITDA2.03
Interest Coverage Ratio19.80
Taxes
In the past 12 months, Fuji Pharma Co., Ltd. has paid 2.13B in taxes.
Income Tax2.13B
Effective Tax Rate0.26
Enterprise Valuation
Fuji Pharma Co., Ltd. EV to EBITDA ratio is 4.58, with an EV/FCF ratio of -251.64.
EV to Sales1.21
EV to EBITDA4.58
EV to Free Cash Flow-251.64
EV to Operating Cash Flow13.40
Balance Sheet
Fuji Pharma Co., Ltd. has €3.70B in cash and marketable securities with ¥30.41B in debt, giving a net cash position of €26.72B billion.
Cash & Marketable Securities€3.70B
Total Debt¥30.41B
Net Cash€26.72B
Net Cash Per Share€1.07K
Tangible Book Value Per Share€1.36K
Margins
Gross margin is 39.92%, with operating margin of 8.41%, and net profit margin of 13.32%.
Gross Margin39.92%
Operating Margin8.41%
Pretax Margin17.94%
Net Profit Margin13.32%
EBITDA Margin26.34%
EBIT Margin18.36%
Analyst Forecast
The average price target for Fuji Pharma Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―